(Q51524033)

6 April 2018

title

HPLC determination of cisatracurium besylate and propofol mixtures with LC-MS identification of degradation products. (English)

1 reference

6 April 2018

1 reference

Zhang H

1

1 reference

6 April 2018

Wang P

series ordinal

2

1 reference

6 April 2018

Bartlett MG

series ordinal

3

1 reference

6 April 2018

Stewart JT

series ordinal

4

1 reference

6 April 2018

publication date

1 March 1998

1 reference

6 April 2018

Journal of Pharmaceutical and Biomedical Analysis

published in

1 reference

6 April 2018

volume

16

1 reference

6 April 2018

issue

7

1 reference

6 April 2018

page(s)

1241-1249

1 reference

6 April 2018

describes a project that uses

liquid chromatography–mass spectrometry

1 reference

Simultaneous determination of atracurium besylate and its major decomposition products and related impurities by reversed-phase high-performance liquid chromatography

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2897%2900262-8

7 January 2021

The in vitro degradation of cisatracurium, the R, cis-R′-isomer of atracurium, in human and rat plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2897%2900262-8

7 January 2021

Identification of urinary and biliary conjugated metabolites of the neuromuscular blocker 51W89 by liquid chromatography/mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2897%2900262-8

7 January 2021

Quantitation of propofol in whole blood by gas chromatography—mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2897%2900262-8

7 January 2021

Determination of plasma propofol levels using gas chromatography—mass spectrometry with selected-ion monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2897%2900262-8

7 January 2021

Quantitation of propofol in plasma by capillary gas chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2897%2900262-8

7 January 2021

The determination of 2,6-diisopropylphenol (propofol) in an oil in water emulsion dosage form by high-performance liquid chromatography and by second d

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2897%2900262-8

7 January 2021

Microdetermination of propofol in plasma by a rapid and sensitive liquid chromatographic method.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2897%2900262-8

7 January 2021

Determination of Propofol in Blood by HPLC. Comparison of the Extraction and Precipitation Methods

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2897%2900262-8

7 January 2021

Rapid and sensitive pre-column extraction high-performance liquid chromatographic assay for propofol in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2897%2900262-8

7 January 2021

Monitoring propofol serum levels by rapid and sensitive reversed-phase high-performance liquid chromatography during prolonged sedation in ICU patients

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2897%2900262-8

7 January 2021

10.1016/S0731-7085(97)00262-8

Identifiers

DOI

1 reference

6 April 2018

1 reference

6 April 2018